Asthma Trial, Recruiting NCT06035289 Sponsor: German Asthma Net e.V. Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT06035289
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children and teenagers (ages 6–18):

  • Children and teenagers between 6 and 18 years old at the time of joining the trial
  • Asthma has been formally diagnosed by a doctor
  • Other conditions that could explain the symptoms have been ruled out
  • The child has been taking their medication as prescribed and has been shown the correct way to use their inhaler
  • Breathing tests show either that the airways open up significantly after using a reliever (rescue) inhaler, or that the airways react strongly to certain triggers during a supervised breathing test
  • The child is on a high level of asthma treatment, which may include: high-dose inhaled steroids alone, medium-to-high dose inhaled steroids combined with other long-term asthma medicines (such as long-acting relievers or leukotriene modifiers), or has been taking steroid tablets for 3 months or more
  • Asthma has been poorly controlled in the past year, shown by: symptoms or use of a reliever inhaler 3 or more times per week, any limitation of activities due to asthma, any asthma symptoms during the night, at least one severe flare-up in the past year requiring steroid tablets for 3 or more days or a hospital stay, or reduced lung function shown on breathing tests
  • A parent or legal guardian has provided written consent for the child to take part

Adults:

  • Adults on a high level of asthma treatment, which may include: high-dose inhaled steroids combined with other long-term asthma medicines, steroid tablets taken for 3 or more months, or treatment with a biological medicine (monoclonal antibody injection)
  • Adults on a medium-to-high dose of inhaled steroids combined with other long-term asthma medicines, AND whose asthma is still poorly controlled — shown by: symptoms or reliever use 3 or more times per week, activity limitations due to asthma, any night-time symptoms, at least one severe flare-up in the past year requiring steroid tablets for 3 or more days, or lung function below 80% of what is expected for that person

Who may not be able to join:

Children and teenagers:

  • Children diagnosed with another lung condition affecting airflow or the whole body, such as cystic fibrosis or COPD (a lung condition called BPD may still be acceptable — confirm with trial site)
  • Children with other lung conditions present from birth, or physical abnormalities of the lungs
  • Children with other significant long-term health conditions
  • Children with heart conditions present from birth or developed later that cause significant physical limitations

Note: No specific exclusion criteria were listed for adults in the source information. Confirm with the trial site whether additional exclusions apply.


Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +49 (0)1577-6948673

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
German Asthma Net e.V.
Registry
ClinicalTrials.gov
Start date
1 November 2011
Est. completion
1 November 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Symptom Control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov